ACTIVITY DETAILS

Pneumococcal Disease in High-Risk Patients: Prevention, Guidelines, and Early Recognition

CMEO Live and On Demand
Premiere Date: Wednesday, June 23, 2010
This activity offers CE credit for:

Physicians (ACCME/AMA PRA Category 1)
Family Physicians (AAFP)
Nurses (CNE)
Pharmacists (ACPE)
All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
Credit Expiration Date:
Thursday, June 23, 2011

Faculty

Larry Culpepper, MD, MPH
Professor and Chairman
Department of Family Medicine
Boston University School of Medicine
Chief, Division of Family Medicine
Boston Medical Center
Boston, MA

Keith P. Klugman, MD, PhD (Moderator)
William H. Foege Professor of Global Health
Rollins School of Public Health
Professor of Medicine, Division of Infectious Diseases
Emory University School of Medicine
Atlanta, GA

Kristin L. Nichol, MD, MPH, MBA
Professor of Medicine
University of Minnesota
Associate Chief of Staff for Research
Minneapolis VA Medical Center
Minneapolis, MN

Michael S. Niederman, MD, FACP, FCCP, FCCM (Guest Interviewee)
Chairman, Department of Medicine
Winthrop-University Hospital
Professor of Medicine
Vice Chairman, Department of Medicine
SUNY at Stony Brook
Mineola, NY

Statement of Need

Pneumococcal disease is a very serious illness in high-risk populations such as children, smokers, the elderly and patients who are immunocompromised. Although the best defense against pneumococcal infection is vaccination, the pneumococcal vaccine remains underutilized in the inpatient setting.(1) Clinicians must be alert to the risk factors for pneumococcal disease, and the high-risk conditions associated with pneumococcal infection for which vaccination is recommended. Guidelines for the prevention and management of pneumococcal disease emphasize the importance of vaccination as well as the need for appropriate and timely antimicrobial therapy.(2) Accurate diagnosis of pneumococcal infection is imperative for early and effective treatment. In this interactive CME Outfitters Live and On Demand activity, faculty will discuss the importance of vaccination for high-risk populations, highlight methods to improve early recognition and diagnosis of pneumococcal disease, and propose practical strategies that can be utilized to advance prevention and treatment for patients at high-risk for pneumococcal infection.

Kruspe R, Lillis R, Daberkow DW 2nd, et al. Education does pay off: pneumococcal vaccine screening and administration in hospitalized adult patients with pneumonia. J La State Med Soc 2003;155:325-331.
Shorr AF, Owens RC Jr. Guidelines and quality for community-acquired pneumonia: measures from the Joint Commission and the Centers for Medicare and Medicaid Services. Am J Health Syst Pharm 2009;66:S2-S7.

Activity Goal

Improve outcomes for patients being treated for pneumococcal disease or who are at high-risk for pneumococcal infection.

Learning Objectives

At the end of this CE activity, participants should be able to:

Recognize the importance of vaccination for the prevention of pneumococcal disease in high-risk patients.
Implement treatment guidelines and recommendations into clinical practice to advance the prevention and treatment of pneumococcal disease.
Identify methods to improve the early recognition and diagnosis of pneumococcal disease.

The following learning objectives pertain only to those requesting CNE credit:

Recognize the importance of vaccination for the prevention of pneumococcal disease in high-risk patients.
Describe treatment guidelines and recommendations for the prevention and treatment of pneumococcal disease.
Identify methods to improve the early recognition and diagnosis of pneumococcal disease.

Target Audience

Infectious disease physicians, primary care physicians, pediatricians, geriatricians, hospitalists, physician assistants, nurse practitioners, nurses, pharmacists, and other healthcare professionals interested in pneumococcal disease and infection.

Financial Support

Supported by an educational grant from Pfizer Inc.

Credit Information

CME Credit (Physicians):
USF Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

USF Health designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.

AAFP Credit (Family Physicians):
This activity, Webinar: Pneumococcal Disease in High-Risk Patients: Prevention, Guidelines, and Early Recognition, with a beginning date of June 23, 2010, has been reviewed and is acceptable for up to 1.00 Prescribed credits by the American Academy of Family Physicians.
AMA/AAFP Equivalency:
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

CNE Credit (Nurses):
(Live activity) This continuing nursing education activity was approved by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation.

It has been assigned approval code 85FHYV-10. 1.0 contact hours will be awarded upon successful completion.

(Archive activity) This continuing nursing education activity was approved by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Centerï¿½s Commission on Accreditation.

It has been assigned approval code 85FHSE-10. 1.0 contact hours will be awarded upon successful completion.

CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Program Number:
376-999-10-013-L01-P (live presentation)
376-999-10-013-H01-P (recorded programs)

Activity Type: knowledge-based

Post-tests, credit request forms, and activity evaluations can be completed online at www.cmeoutfitters.com/test, and participants can print their certificate or statement of credit immediately (70% pass rate required). This website supports all browsers except Internet Explorer for Mac.

This continuing education activity is co-sponsored by USF Health and by CME Outfitters, LLC.

Disclosure of Relevant Financial Relationships with Commercial Interests

USF Health endorses the standards of the ACCME that requires everyone in a position to control the content of a CME activity to disclose all financial relationships with commercial interests that are related to the content of the CME activity. CME activities must be balanced, independent of commercial bias and promote improvements or quality in healthcare. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.

A conflict of interest is created when individuals in a position to control the content of CME have a relevant financial relationship with a commercial interest which therefore may bias his/her opinion and teaching. This may include receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, stocks or other financial benefits.

USF Health will identify, review and resolve all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Relevant financial relationships exist between the following individuals and commercial interests:

Professor Klugman has disclosed that he serves as a consultant to Dow Pharmaceutical Sciences, Inc., Forest Laboratories, GlaxoSmithKline, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, and Wyeth Pharmaceuticals (Pfizer Inc.). He receives research/grants from Pfizer Inc.

Dr. Culpepper has disclosed that he serves as a consultant to AstraZeneca Pharmaceuticals LP, Labopharm Inc., Lilly USA, LLC, Merck & Co., Inc., Pfizer Inc., Sanofi-aventis, and Takeda Pharmaceuticals North America, Inc. He receives research/grants from Forest Laboratories Pharmaceuticals, Inc., and Pfizer Inc.

Dr. Nichol has disclosed that she serves as a consultant to and is on the advisory boards of GlaxoSmithKline, Novartis Pharmaceuticals Corporation, and Wyeth Pharmaceuticals (Pfizer Inc.).

Dr. Niederman has disclosed that he is on the advisory boards of and serves as a consultant to GlaxoSmithKline, Novartis Pharmaceuticals Corporation, and Wyeth Pharmaceuticals (Pfizer Inc.).

Disclosures were obtained from the planning committee members and are on file in the USF Health, Office of Continuing Professional Development (OCPD) for review. Disclosures were obtained from the USF Health OCPD staff: Nothing to Disclose.

Unlabeled Use Disclosure

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

USF Health, CME Outfitters, LLC, the faculty, and Pfizer Inc. do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).

TV-067-062310-02